The Cognitive Neuroscience Group at the MGH Institute of Health Professions in Boston is recruiting children between the ages of 8 and 12 years to participate in research studies funded by the National Science Foundation (NSF) and the National Institute of Health (NIH).
Study 1. This is a longitudinal study that follows children over a period of 3 consecutive years. The goal is to improve understanding of learning in children. The study consists of 1 in-person visit (about 2.5 hours scheduled on weekdays and weekends) per year for 3 years. During this visit, children play several games on the computer and complete several language/memory tasks. The lab visit includes safe and noninvasive EEG recording. The day after the visit, kids complete a quick follow-up task from a home/library computer. More information can be found at https://clinicaltrials.partners.org/study/feedback_learning
Study 2. The purpose of the study is to evaluate the learning patterns of children with typical and atypical language development. The study will involve 2 visits to the lab at the MGH Institute of Health Professions. During the visits, children complete a battery of cognitive and language-based assessments, play several games on the computer and complete several language/memory tasks. The lab visit includes safe and noninvasive EEG recording. A visit will last about 3 hours. A week after the second lab visit your child will be asked to complete follow up tasks on a home computer or a mobile device. Researchers are looking for children who were late to develop language, and who still receive services for language or learning difficulties. More information can be found at https://rally.partners.org/study/does_your_child_stru
Payment is $60 for each in-person visit to the lab and there is free all-day parking provided at the Navy Yard. Results of your child’s cognitive and language-based assessments are mailed to you. Please email cnglead@mghihp.edu or call 617- 724-7363 if you are interested or if you have any questions.
Thank you,
Isabel Fitzpatrick and The LEAD Study Team